img

Global Diabetes Mellitus Drugs Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Diabetes Mellitus Drugs Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia.High blood sugar is caused by defective secretion of insulin or impaired biological function, or both.Long-term hyperglycemia leads to chronic damage and dysfunction of various tissues, especially eyes, kidneys, heart, blood vessels and nerves.
Due to the COVID-19 pandemic, the global Diabetes Mellitus Drugs market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Oral Medicine accounting for % of the Diabetes Mellitus Drugs global market in 2022, is projected to value US$ million by 2034, growing at a revised % CAGR from 2024 to 2034. While Hospital segment is altered to an % CAGR throughout this forecast period.
The global key companies of Diabetes Mellitus Drugs include Novo Nordisk, Merck & Co, Boehringer Ingelheim, AstraZeneca, Eli Lilly and Company, Johnson & Johnson, Takeda, Sanofi and Gan & Lee Pharmaceuticals, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
The United States Diabetes Mellitus Drugs market size was US$ million in 2022, while China size was US$ million. The proportion of the United States was % in 2022, while China percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period. As for the Europe Diabetes Mellitus Drugs landscape, Germany is projected to reach US$ million by 2034. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Diabetes Mellitus Drugs market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Diabetes Mellitus Drugs market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Diabetes Mellitus Drugs market. Readers of the report can become informed about current and future trends of the global Diabetes Mellitus Drugs market and how they will impact market growth during the forecast period.



By Company


Novo Nordisk
Merck & Co
Boehringer Ingelheim
AstraZeneca
Eli Lilly and Company
Johnson & Johnson
Takeda
Sanofi
Gan & Lee Pharmaceuticals
Bayer
Tonghua Dongbao Pharmaceutical Co
Huadong Medicine
Segment by Type
Oral Medicine
Injection Medicine

Segment by Application


Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of Diabetes Mellitus Drugs in global and regional level.
Chapter 3Detailed analysis of Diabetes Mellitus Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diabetes Mellitus Drugs revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Mellitus Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2034
1.2.2 Oral Medicine
1.2.3 Injection Medicine
1.3 Market by Application
1.3.1 Global Diabetes Mellitus Drugs Market Growth Rate by Application: 2018 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Diabetes Mellitus Drugs Market Size (2018-2034)
2.2 Diabetes Mellitus Drugs Market Size across Key Geographies Worldwide: 2018 VS 2022 VS 2034
2.3 Global Diabetes Mellitus Drugs Market Size by Region (2018-2024)
2.4 Global Diabetes Mellitus Drugs Market Size Forecast by Region (2024-2034)
2.5 Global Top 10 Diabetes Mellitus Drugs Countries Ranking by Market Size
3 Diabetes Mellitus Drugs Competitive by Company
3.1 Global Diabetes Mellitus Drugs Revenue by Players
3.1.1 Global Diabetes Mellitus Drugs Revenue by Players (2018-2024)
3.1.2 Global Diabetes Mellitus Drugs Market Share by Players (2018-2024)
3.2 Global Diabetes Mellitus Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Diabetes Mellitus Drugs Revenue
3.4 Global Diabetes Mellitus Drugs Market Concentration Ratio
3.4.1 Global Diabetes Mellitus Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Mellitus Drugs Revenue in 2022
3.5 Global Key Players of Diabetes Mellitus Drugs Head office and Area Served
3.6 Global Key Players of Diabetes Mellitus Drugs, Product and Application
3.7 Global Key Players of Diabetes Mellitus Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Diabetes Mellitus Drugs Breakdown Data by Type
4.1 Global Diabetes Mellitus Drugs Historic Revenue by Type (2018-2024)
4.2 Global Diabetes Mellitus Drugs Forecasted Revenue by Type (2024-2034)
5 Global Diabetes Mellitus Drugs Breakdown Data by Application
5.1 Global Diabetes Mellitus Drugs Historic Market Size by Application (2018-2024)
5.2 Global Diabetes Mellitus Drugs Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Diabetes Mellitus Drugs Revenue by Company (2021-2024)
6.2 North America Diabetes Mellitus Drugs Revenue by Type (2018-2034)
6.3 North America Diabetes Mellitus Drugs Revenue by Application (2018-2034)
6.4 North America Diabetes Mellitus Drugs Revenue by Country (2018-2034)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Diabetes Mellitus Drugs Revenue by Company (2021-2024)
7.2 Europe Diabetes Mellitus Drugs Revenue by Type (2018-2034)
7.3 Europe Diabetes Mellitus Drugs Revenue by Application (2018-2034)
7.4 Europe Diabetes Mellitus Drugs Revenue by Country (2018-2034)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Diabetes Mellitus Drugs Revenue by Company (2021-2024)
8.2 Asia Pacific Diabetes Mellitus Drugs Revenue by Type (2018-2034)
8.3 Asia Pacific Diabetes Mellitus Drugs Revenue by Application (2018-2034)
8.4 Asia Pacific Diabetes Mellitus Drugs Revenue by Region (2018-2034)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America Diabetes Mellitus Drugs Revenue by Company (2021-2024)
9.2 Latin America Diabetes Mellitus Drugs Revenue by Type (2018-2034)
9.3 Latin America Diabetes Mellitus Drugs Revenue by Application (2018-2034)
9.4 Latin America Diabetes Mellitus Drugs Revenue by Country (2018-2034)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Diabetes Mellitus Drugs Revenue by Company (2021-2024)
10.2 Middle East and Africa Diabetes Mellitus Drugs Revenue by Type (2018-2034)
10.3 Middle East and Africa Diabetes Mellitus Drugs Revenue by Application (2018-2034)
10.4 Middle East and Africa Diabetes Mellitus Drugs Revenue by Country (2018-2034)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Details
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Diabetes Mellitus Drugs Products and Services
11.1.4 Novo Nordisk Diabetes Mellitus Drugs Revenue in Diabetes Mellitus Drugs Business (2018-2024)
11.1.5 Novo Nordisk Diabetes Mellitus Drugs SWOT Analysis
11.1.6 Novo Nordisk Recent Development
11.2 Merck & Co
11.2.1 Merck & Co Company Details
11.2.2 Merck & Co Business Overview
11.2.3 Merck & Co Diabetes Mellitus Drugs Products and Services
11.2.4 Merck & Co Diabetes Mellitus Drugs Revenue in Diabetes Mellitus Drugs Business (2018-2024)
11.2.5 Merck & Co Diabetes Mellitus Drugs SWOT Analysis
11.2.6 Merck & Co Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Diabetes Mellitus Drugs Products and Services
11.3.4 Boehringer Ingelheim Diabetes Mellitus Drugs Revenue in Diabetes Mellitus Drugs Business (2018-2024)
11.3.5 Boehringer Ingelheim Diabetes Mellitus Drugs SWOT Analysis
11.3.6 Boehringer Ingelheim Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Diabetes Mellitus Drugs Products and Services
11.4.4 AstraZeneca Diabetes Mellitus Drugs Revenue in Diabetes Mellitus Drugs Business (2018-2024)
11.4.5 AstraZeneca Diabetes Mellitus Drugs SWOT Analysis
11.4.6 AstraZeneca Recent Development
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Details
11.5.2 Eli Lilly and Company Business Overview
11.5.3 Eli Lilly and Company Diabetes Mellitus Drugs Products and Services
11.5.4 Eli Lilly and Company Diabetes Mellitus Drugs Revenue in Diabetes Mellitus Drugs Business (2018-2024)
11.5.5 Eli Lilly and Company Diabetes Mellitus Drugs SWOT Analysis
11.5.6 Eli Lilly and Company Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Diabetes Mellitus Drugs Products and Services
11.6.4 Johnson & Johnson Diabetes Mellitus Drugs Revenue in Diabetes Mellitus Drugs Business (2018-2024)
11.6.5 Johnson & Johnson Diabetes Mellitus Drugs SWOT Analysis
11.6.6 Johnson & Johnson Recent Development
11.7 Takeda
11.7.1 Takeda Company Details
11.7.2 Takeda Business Overview
11.7.3 Takeda Diabetes Mellitus Drugs Products and Services
11.7.4 Takeda Diabetes Mellitus Drugs Revenue in Diabetes Mellitus Drugs Business (2018-2024)
11.7.5 Takeda Diabetes Mellitus Drugs SWOT Analysis
11.7.6 Takeda Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Diabetes Mellitus Drugs Products and Services
11.8.4 Sanofi Diabetes Mellitus Drugs Revenue in Diabetes Mellitus Drugs Business (2018-2024)
11.8.5 Sanofi Diabetes Mellitus Drugs SWOT Analysis
11.8.6 Sanofi Recent Development
11.9 Gan & Lee Pharmaceuticals
11.9.1 Gan & Lee Pharmaceuticals Company Details
11.9.2 Gan & Lee Pharmaceuticals Business Overview
11.9.3 Gan & Lee Pharmaceuticals Diabetes Mellitus Drugs Products and Services
11.9.4 Gan & Lee Pharmaceuticals Diabetes Mellitus Drugs Revenue in Diabetes Mellitus Drugs Business (2018-2024)
11.9.5 Gan & Lee Pharmaceuticals Diabetes Mellitus Drugs SWOT Analysis
11.9.6 Gan & Lee Pharmaceuticals Recent Development
11.10 Bayer
11.10.1 Bayer Company Details
11.10.2 Bayer Business Overview
11.10.3 Bayer Diabetes Mellitus Drugs Products and Services
11.10.4 Bayer Diabetes Mellitus Drugs Revenue in Diabetes Mellitus Drugs Business (2018-2024)
11.10.5 Bayer Diabetes Mellitus Drugs SWOT Analysis
11.10.6 Bayer Recent Development
11.11 Tonghua Dongbao Pharmaceutical Co
11.11.1 Tonghua Dongbao Pharmaceutical Co Company Details
11.11.2 Tonghua Dongbao Pharmaceutical Co Business Overview
11.11.3 Tonghua Dongbao Pharmaceutical Co Diabetes Mellitus Drugs Products and Services
11.11.4 Tonghua Dongbao Pharmaceutical Co Diabetes Mellitus Drugs Revenue in Diabetes Mellitus Drugs Business (2018-2024)
11.11.5 Tonghua Dongbao Pharmaceutical Co Recent Development
11.12 Huadong Medicine
11.12.1 Huadong Medicine Company Details
11.12.2 Huadong Medicine Business Overview
11.12.3 Huadong Medicine Diabetes Mellitus Drugs Products and Services
11.12.4 Huadong Medicine Diabetes Mellitus Drugs Revenue in Diabetes Mellitus Drugs Business (2018-2024)
11.12.5 Huadong Medicine Recent Development
12 Diabetes Mellitus Drugs Market Dynamics
12.1 Diabetes Mellitus Drugs Industry Trends
12.2 Diabetes Mellitus Drugs Market Drivers
12.3 Diabetes Mellitus Drugs Market Challenges
12.4 Diabetes Mellitus Drugs Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global Diabetes Mellitus Drugs Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Oral Medicine
Table 3. Key Players of Injection Medicine
Table 4. Global Diabetes Mellitus Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 5. Global Diabetes Mellitus Drugs Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
Table 6. Global Diabetes Mellitus Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Diabetes Mellitus Drugs Revenue Forecast by Region (2024-2034) & (US$ Million)
Table 8. Global Diabetes Mellitus Drugs Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Table 9. Global Diabetes Mellitus Drugs Revenue by Players (2018-2024) & (US$ Million)
Table 10. Global Diabetes Mellitus Drugs Market Share by Players (2018-2024)
Table 11. Global Top Diabetes Mellitus Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Mellitus Drugs as of 2022)
Table 12. Ranking of Global Top Diabetes Mellitus Drugs Companies by Revenue (US$ Million) in 2022
Table 13. Global 5 Largest Players Market Share by Diabetes Mellitus Drugs Revenue (CR5 and HHI) & (2018-2024)
Table 14. Global Key Players of Diabetes Mellitus Drugs, Headquarters and Area Served
Table 15. Global Key Players of Diabetes Mellitus Drugs, Product and Application
Table 16. Global Key Players of Diabetes Mellitus Drugs, Date of Enter into This Industry
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global Diabetes Mellitus Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 19. Global Diabetes Mellitus Drugs Revenue Market Share by Type (2018-2024)
Table 20. Global Diabetes Mellitus Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 21. Global Diabetes Mellitus Drugs Revenue Market Share by Type (2024-2034)
Table 22. Global Diabetes Mellitus Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Diabetes Mellitus Drugs Revenue Market Share by Application (2018-2024)
Table 24. Global Diabetes Mellitus Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Diabetes Mellitus Drugs Revenue Market Share by Application (2024-2034)
Table 26. North America Diabetes Mellitus Drugs Revenue by Company (2021-2024) & (US$ Million)
Table 27. North America Diabetes Mellitus Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 28. North America Diabetes Mellitus Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 29. North America Diabetes Mellitus Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 30. North America Diabetes Mellitus Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 31. North America Diabetes Mellitus Drugs Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 32. North America Diabetes Mellitus Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 33. North America Diabetes Mellitus Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 34. Europe Diabetes Mellitus Drugs Revenue by Company (2021-2024) & (US$ Million)
Table 35. Europe Diabetes Mellitus Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 36. Europe Diabetes Mellitus Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 37. Europe Diabetes Mellitus Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 38. Europe Diabetes Mellitus Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 39. Europe Diabetes Mellitus Drugs Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 40. Europe Diabetes Mellitus Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 41. Europe Diabetes Mellitus Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 42. Asia Pacific Diabetes Mellitus Drugs Revenue by Company (2021-2024) & (US$ Million)
Table 43. Asia Pacific Diabetes Mellitus Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 44. Asia Pacific Diabetes Mellitus Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 45. Asia Pacific Diabetes Mellitus Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 46. Asia Pacific Diabetes Mellitus Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 47. Asia-Pacific Diabetes Mellitus Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 48. Asia Pacific Diabetes Mellitus Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 49. Asia Pacific Diabetes Mellitus Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 50. Latin America Diabetes Mellitus Drugs Revenue by Company (2021-2024) & (US$ Million)
Table 51. Latin America Diabetes Mellitus Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 52. Latin America Diabetes Mellitus Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 53. Latin America Diabetes Mellitus Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 54. Latin America Diabetes Mellitus Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 55. Latin America Diabetes Mellitus Drugs Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 56. Latin America Diabetes Mellitus Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 57. Latin America Diabetes Mellitus Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 58. Middle East and Africa Diabetes Mellitus Drugs Revenue by Company (2021-2024) & (US$ Million)
Table 59. Middle East and Africa Diabetes Mellitus Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 60. Middle East and Africa Diabetes Mellitus Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 61. Middle East and Africa Diabetes Mellitus Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 62. Middle East and Africa Diabetes Mellitus Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 63. Middle East and Africa Diabetes Mellitus Drugs Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 64. Middle East and Africa Diabetes Mellitus Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Diabetes Mellitus Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 66. Novo Nordisk Company Details
Table 67. Novo Nordisk Business Overview
Table 68. Novo Nordisk Diabetes Mellitus Drugs Product and Services
Table 69. Novo Nordisk Diabetes Mellitus Drugs Revenue in Diabetes Mellitus Drugs Business (2018-2024) & (US$ Million)
Table 70. Novo Nordisk Diabetes Mellitus Drugs SWOT Analysis
Table 71. Novo Nordisk Recent Development
Table 72. Merck & Co Company Details
Table 73. Merck & Co Business Overview
Table 74. Merck & Co Diabetes Mellitus Drugs Product and Services
Table 75. Merck & Co Diabetes Mellitus Drugs Revenue in Diabetes Mellitus Drugs Business (2018-2024) & (US$ Million)
Table 76. Merck & Co Diabetes Mellitus Drugs SWOT Analysis
Table 77. Merck & Co Recent Development
Table 78. Boehringer Ingelheim Company Details
Table 79. Boehringer Ingelheim Business Overview
Table 80. Boehringer Ingelheim Diabetes Mellitus Drugs Product and Services
Table 81. Boehringer Ingelheim Diabetes Mellitus Drugs Revenue in Diabetes Mellitus Drugs Business (2018-2024) & (US$ Million)
Table 82. Boehringer Ingelheim Diabetes Mellitus Drugs SWOT Analysis
Table 83. Boehringer Ingelheim Recent Development
Table 84. AstraZeneca Company Details
Table 85. AstraZeneca Business Overview
Table 86. AstraZeneca Diabetes Mellitus Drugs Product and Services
Table 87. AstraZeneca Diabetes Mellitus Drugs Revenue in Diabetes Mellitus Drugs Business (2018-2024) & (US$ Million)
Table 88. AstraZeneca Diabetes Mellitus Drugs SWOT Analysis
Table 89. AstraZeneca Recent Development
Table 90. Eli Lilly and Company Company Details
Table 91. Eli Lilly and Company Business Overview
Table 92. Eli Lilly and Company Diabetes Mellitus Drugs Product and Services
Table 93. Eli Lilly and Company Diabetes Mellitus Drugs Revenue in Diabetes Mellitus Drugs Business (2018-2024) & (US$ Million)
Table 94. Eli Lilly and Company Diabetes Mellitus Drugs SWOT Analysis
Table 95. Eli Lilly and Company Recent Development
Table 96. Johnson & Johnson Company Details
Table 97. Johnson & Johnson Business Overview
Table 98. Johnson & Johnson Diabetes Mellitus Drugs Product and Services
Table 99. Johnson & Johnson Diabetes Mellitus Drugs Revenue in Diabetes Mellitus Drugs Business (2018-2024) & (US$ Million)
Table 100. Johnson & Johnson Diabetes Mellitus Drugs SWOT Analysis
Table 101. Johnson & Johnson Recent Development
Table 102. Takeda Company Details
Table 103. Takeda Business Overview
Table 104. Takeda Diabetes Mellitus Drugs Product and Services
Table 105. Takeda Diabetes Mellitus Drugs Revenue in Diabetes Mellitus Drugs Business (2018-2024) & (US$ Million)
Table 106. Takeda Diabetes Mellitus Drugs SWOT Analysis
Table 107. Takeda Recent Development
Table 108. Sanofi Company Details
Table 109. Sanofi Business Overview
Table 110. Sanofi Diabetes Mellitus Drugs Product and Services
Table 111. Sanofi Diabetes Mellitus Drugs Revenue in Diabetes Mellitus Drugs Business (2018-2024) & (US$ Million)
Table 112. Sanofi Diabetes Mellitus Drugs SWOT Analysis
Table 113. Sanofi Recent Development
Table 114. Gan & Lee Pharmaceuticals Company Details
Table 115. Gan & Lee Pharmaceuticals Business Overview
Table 116. Gan & Lee Pharmaceuticals Diabetes Mellitus Drugs Product and Services
Table 117. Gan & Lee Pharmaceuticals Diabetes Mellitus Drugs Revenue in Diabetes Mellitus Drugs Business (2018-2024) & (US$ Million)
Table 118. Gan & Lee Pharmaceuticals Diabetes Mellitus Drugs SWOT Analysis
Table 119. Gan & Lee Pharmaceuticals Recent Development
Table 120. Bayer Company Details
Table 121. Bayer Business Overview
Table 122. Bayer Diabetes Mellitus Drugs Product and Services
Table 123. Bayer Diabetes Mellitus Drugs Revenue in Diabetes Mellitus Drugs Business (2018-2024) & (US$ Million)
Table 124. Bayer Diabetes Mellitus Drugs SWOT Analysis
Table 125. Bayer Recent Development
Table 126. Tonghua Dongbao Pharmaceutical Co Company Details
Table 127. Tonghua Dongbao Pharmaceutical Co Business Overview
Table 128. Tonghua Dongbao Pharmaceutical Co Diabetes Mellitus Drugs Product and Services
Table 129. Tonghua Dongbao Pharmaceutical Co Diabetes Mellitus Drugs Revenue in Diabetes Mellitus Drugs Business (2018-2024) & (US$ Million)
Table 130. Tonghua Dongbao Pharmaceutical Co Recent Development
Table 131. Huadong Medicine Company Details
Table 132. Huadong Medicine Business Overview
Table 133. Huadong Medicine Diabetes Mellitus Drugs Product and Services
Table 134. Huadong Medicine Diabetes Mellitus Drugs Revenue in Diabetes Mellitus Drugs Business (2018-2024) & (US$ Million)
Table 135. Huadong Medicine Recent Development
Table 136. Diabetes Mellitus Drugs Market Trends
Table 137. Diabetes Mellitus Drugs Market Drivers
Table 138. Diabetes Mellitus Drugs Market Challenges
Table 139. Diabetes Mellitus Drugs Market Restraints
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Diabetes Mellitus Drugs Product Picture
Figure 2. Global Diabetes Mellitus Drugs Market Size by Type (US$ Million): 2018 VS 2022 VS 2034
Figure 3. Global Diabetes Mellitus Drugs Market Share by Type: 2022 VS 2034
Figure 4. Oral Medicine Features
Figure 5. Injection Medicine Features
Figure 6. Global Diabetes Mellitus Drugs Market Size by Application (US$ Million): 2018 VS 2022 VS 2034
Figure 7. Global Diabetes Mellitus Drugs Market Share by Application: 2022 VS 2034
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Diabetes Mellitus Drugs Report Years Considered
Figure 12. Global Diabetes Mellitus Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Diabetes Mellitus Drugs Market Size 2018-2034 (US$ Million)
Figure 14. Global Diabetes Mellitus Drugs Market Size Market Share by Region: 2022 VS 2034
Figure 15. Global Diabetes Mellitus Drugs Revenue Market Share by Region in 2018 VS 2022
Figure 16. Global Diabetes Mellitus Drugs Revenue Market Share Forecast by Region (2024-2034)
Figure 17. Global Top 10 Diabetes Mellitus Drugs Countries Ranking by Market Size (US$ Million) in 2022
Figure 18. Global Diabetes Mellitus Drugs Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Figure 19. Global Diabetes Mellitus Drugs Market Share by Players in 2022
Figure 20. Global Top Diabetes Mellitus Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Mellitus Drugs as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Diabetes Mellitus Drugs Revenue in 2022
Figure 22. North America Diabetes Mellitus Drugs Revenue Market Share by Company in 2022
Figure 23. North America Diabetes Mellitus Drugs Revenue Market Share by Type (2018-2034)
Figure 24. North America Diabetes Mellitus Drugs Revenue Market Share by Application (2018-2034)
Figure 25. North America Diabetes Mellitus Drugs Revenue Share by Country (2018-2034)
Figure 26. United States Diabetes Mellitus Drugs Revenue (2018-2034) & (US$ Million)
Figure 27. Canada Diabetes Mellitus Drugs Revenue (2018-2034) & (US$ Million)
Figure 28. Europe Diabetes Mellitus Drugs Revenue Market Share by Company in 2022
Figure 29. Europe Diabetes Mellitus Drugs Revenue Market Share by Type (2018-2034)
Figure 30. Europe Diabetes Mellitus Drugs Revenue Market Share by Application (2018-2034)
Figure 31. Europe Diabetes Mellitus Drugs Revenue Share by Country (2018-2034)
Figure 32. Germany Diabetes Mellitus Drugs Revenue (2018-2034) & (US$ Million)
Figure 33. France Diabetes Mellitus Drugs Revenue (2018-2034) & (US$ Million)
Figure 34. U.K. Diabetes Mellitus Drugs Revenue (2018-2034) & (US$ Million)
Figure 35. Italy Diabetes Mellitus Drugs Revenue (2018-2034) & (US$ Million)
Figure 36. Russia Diabetes Mellitus Drugs Revenue (2018-2034) & (US$ Million)
Figure 37. Asia Pacific Diabetes Mellitus Drugs Revenue Market Share by Company in 2022
Figure 38. Asia Pacific Diabetes Mellitus Drugs Revenue Market Share by Type (2018-2034)
Figure 39. Asia Pacific Diabetes Mellitus Drugs Revenue Market Share by Application (2018-2034)
Figure 40. Asia Pacific Diabetes Mellitus Drugs Revenue Share by Region (2018-2034)
Figure 41. China Diabetes Mellitus Drugs Revenue (2018-2034) & (US$ Million)
Figure 42. Japan Diabetes Mellitus Drugs Revenue (2018-2034) & (US$ Million)
Figure 43. South Korea Diabetes Mellitus Drugs Revenue (2018-2034) & (US$ Million)
Figure 44. India Diabetes Mellitus Drugs Revenue (2018-2034) & (US$ Million)
Figure 45. Australia Diabetes Mellitus Drugs Revenue (2018-2034) & (US$ Million)
Figure 46. China Taiwan Diabetes Mellitus Drugs Revenue (2018-2034) & (US$ Million)
Figure 47. Indonesia Diabetes Mellitus Drugs Revenue (2018-2034) & (US$ Million)
Figure 48. Thailand Diabetes Mellitus Drugs Revenue (2018-2034) & (US$ Million)
Figure 49. Malaysia Diabetes Mellitus Drugs Revenue (2018-2034) & (US$ Million)
Figure 50. Latin America Diabetes Mellitus Drugs Revenue Market Share by Company in 2022
Figure 51. Latin America Diabetes Mellitus Drugs Revenue Market Share by Type (2018-2034)
Figure 52. Latin America Diabetes Mellitus Drugs Revenue Market Share by Application (2018-2034)
Figure 53. Latin America Diabetes Mellitus Drugs Revenue Share by Country (2018-2034)
Figure 54. Mexico Diabetes Mellitus Drugs Revenue (2018-2034) & (US$ Million)
Figure 55. Brazil Diabetes Mellitus Drugs Revenue (2018-2034) & (US$ Million)
Figure 56. Argentina Diabetes Mellitus Drugs Revenue (2018-2034) & (US$ Million)
Figure 57. Middle East and Africa Diabetes Mellitus Drugs Revenue Market Share by Company in 2022
Figure 58. Middle East and Africa Diabetes Mellitus Drugs Revenue Market Share by Type (2018-2034)
Figure 59. Middle East and Africa Diabetes Mellitus Drugs Revenue Market Share by Application (2018-2034)
Figure 60. Middle East and Africa Diabetes Mellitus Drugs Revenue Share by Country (2018-2034)
Figure 61. Turkey Diabetes Mellitus Drugs Revenue (2018-2034) & (US$ Million)
Figure 62. Saudi Arabia Diabetes Mellitus Drugs Revenue (2018-2034) & (US$ Million)
Figure 63. UAE Diabetes Mellitus Drugs Revenue (2018-2034) & (US$ Million)
Figure 64. Novo Nordisk Revenue Growth Rate in Diabetes Mellitus Drugs Business (2018-2024)
Figure 65. Merck & Co Revenue Growth Rate in Diabetes Mellitus Drugs Business (2018-2024)
Figure 66. Boehringer Ingelheim Revenue Growth Rate in Diabetes Mellitus Drugs Business (2018-2024)
Figure 67. AstraZeneca Revenue Growth Rate in Diabetes Mellitus Drugs Business (2018-2024)
Figure 68. Eli Lilly and Company Revenue Growth Rate in Diabetes Mellitus Drugs Business (2018-2024)
Figure 69. Johnson & Johnson Revenue Growth Rate in Diabetes Mellitus Drugs Business (2018-2024)
Figure 70. Takeda Revenue Growth Rate in Diabetes Mellitus Drugs Business (2018-2024)
Figure 71. Sanofi Revenue Growth Rate in Diabetes Mellitus Drugs Business (2018-2024)
Figure 72. Gan & Lee Pharmaceuticals Revenue Growth Rate in Diabetes Mellitus Drugs Business (2018-2024)
Figure 73. Bayer Revenue Growth Rate in Diabetes Mellitus Drugs Business (2018-2024)
Figure 74. Tonghua Dongbao Pharmaceutical Co Revenue Growth Rate in Diabetes Mellitus Drugs Business (2018-2024)
Figure 75. Huadong Medicine Revenue Growth Rate in Diabetes Mellitus Drugs Business (2018-2024)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed